SMB congratulates Khondrion on the start of the KHENERGY study, a phase 2 clinical trial of KH176 in MELAS/MIDD and mixed mitochondrial syndromes! For more information on the clinical trial please refer to the Press release from Khondrion.
“Door de ondersteuning van SMB is inzicht verkregen in de financiële situatie van onze projecten”
Ard Peeters, ChardonPharmaSMB congratulates Khondrion on the start of the KHENERGY study, a phase 2 clinical trial of KH176 in MELAS/MIDD and mixed mitochondrial syndromes! For more information on the clinical trial please refer to the Press release from Khondrion.